Convatec announced that it received FDA approval for the delivery of a Parkinson's disease therapy through its Neria Guard ...

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...

Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

The components of the Eversense 365 CGM. [Image courtesy of Senseonics/Ascensia] Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...

(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

The system — similar to continuous glucose monitoring (CGM) uses a new method of continuously sensing specific chemistry ...

LifePlus announced the clinical validation of its non-invasive and cuffless wearable for continuous glucose and blood ...

For many, a partnership between Abbott and Medtronic, two medtech giants and frequent competitors, would have seemed unlikely ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...